Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Laser Tissue Interactions in Scar Treatment and Skin Rejuvenation: Histology, Imaging, and Device Selection
Description
The speaker reviewed laser and energy-based device interactions in scar treatment and skin rejuvenation, emphasizing that device choice and settings must be tailored to scar characteristics, treatment goals, and skin type. Using histology, imaging, and OCT, the talk explained how different devices create injury through mechanical channels, thermal coagulation, cavitation, ablation, or ultrasound-generated heat. Microneedling was described as a purely mechanical, all-skin-type-safe option that can enhance drug delivery, though channels close quickly and topical timing matters. Radiofrequency microneedling and focal RF devices were presented as effective for rejuvenation and small scars, while fractional picosecond lasers create cavitation with minimal thermal damage and may be safer for darker skin. Monopolar RF and ultrasound devices produce deeper coagulation and tightening, with energy and depth varying by setting. Ablative fractional lasers, including CO2 and erbium-based devices, were highlighted for scar remodeling and laser-assisted drug delivery, especially when larger channels are needed. Non-ablative fractional lasers were shown to create limited coagulation without channels, making them useful for superficial concerns like lentigines and PIH but less suited for deep drug delivery. Finally, the speaker noted that high-energy, low-density settings can reduce PIH risk, and that full-field ablative lasers are most aggressive and generally less suitable for darker skin. Overall, treatment selection should be guided by pathology depth, lesion size, skin type, and the mechanism of the device.
View moreConclusions
- Device and parameter selection for scars and rejuvenation should be individualized to the patient’s skin type, scar depth, scar size, and the mechanism of the energy-based device.
- Microneedling is a purely mechanical, non-thermal treatment that is broadly safe across skin types, and it can also be useful for drug delivery when timing and drug properties are optimized.
- Laser-assisted or device-assisted drug delivery works best when the treatment creates channels large enough for the drug or filler being used, and application timing can materially affect penetration depth.
- Fractional radiofrequency microneedling appears to provide stronger rejuvenation and wrinkle improvement than microneedling alone, with deeper collagen remodeling and less evidence of cellular senescence.
- Fractional picosecond lasers create laser-induced optical breakdown without thermal injury and are particularly useful for scar remodeling and erythematous scars, with superficial cavitation generally making them safer for darker skin.
- Monopolar radiofrequency and focused ultrasound both achieve dermal tightening by controlled thermal coagulation while largely sparing the epidermis, making them useful options for rejuvenation in skin of color.
- Ablative fractional lasers create larger channels and more substantial tissue vaporization, which makes them especially effective for drug delivery and for treating more pronounced scar pathology.
- Non-ablative fractional lasers cause limited coagulation with little or no ablative channel formation, so they are safer and better suited for more superficial indications, but they are less effective for delivering large particles or deep dermal payloads.
- Higher water absorption generally produces shallower penetration, explaining why 1,927-nm lasers are better for superficial pigment problems while 1,540/1,550-nm lasers reach deeper dermis.
- Lower density and higher-energy fractional settings reduce the risk of post-inflammatory hyperpigmentation compared with denser treatment patterns, especially in skin of color.
- Fully ablative lasers remain effective for selected small facial areas and deeper resurfacing indications, but they cause prolonged wound healing and are generally not recommended for darker skin types.
- Overall, the safest and most effective approach is to match the device and settings to the target tissue depth and desired injury pattern while minimizing epidermal damage and pigmentary risk.
- Lasers Surg Med. 2024 Jan;56(1):11-13.
- J Am Acad Dermatol. 2025 Jan;92(1):78-84.
- J Cosmet Dermatol. 2014 Sep;13(3):180-187.
- Dermatol Surg. 2020 Dec;46(12):e146-153.
- Dermatol Surg. 2022 Apr;48(4):441-448.
- Lasers Surg Med. 2025 Aug;57(6):528-543.
- Sci Rep. 2025 May 26;15:18296.
- Lasers Med Sci. 2019 Aug;34(6):1207-1215.
- Lasers Surg Med. 2021 Oct;53(8):1059-1064.
- J Am Acad Dermatol. 2016 May;74(5):931–936.
- Sci Rep. 2019 Mar 12;9(1):4186.
- Lasers Surg Med. 2021, 2024, 2020, 2023, and 2023 citations.
- Arch Dermatol. 2004.
- Lasers Surg Med. 2006.
- Biophys J. 2011 Jul 6;101(1):228-236.
- J Cosmet Laser Ther. 2015;17(5):230-236.
- Dermatol Surg. 2021 Dec 1;47(12):1585-1589.
- J Cosmet Dermatol. 2024 Jan;23(1):117-123.
- Modified from Dermatol Surg. 2011 Aug;37(8):1141-1149.
- JAAD Case Rep. 2019 Sep 24;5(10):840-843.
- Dermatol Surg. 2014 and 2025 at the bottom.
- J Drugs Dermatol. 2014 Nov;13(11):1317-1322.
- Lasers Surg Med. 2007 Jun;39(5):381-5. doi: 10.1002/lsm.20512.#10.1002/lsm.20512
- Modified from Dermatol Surg. 1999 Dec;25(12):926-930.
- J Drugs Dermatol. 2015 Nov;14(11):1363-1366.
- J Cosmet Laser Ther. 2016;18(1):31-37.